eyeforpharma Philadelphia Awards

May 2, 2016 - May 2, 2016, Philadelphia

The search for the most valuable and innovative patient-centric initiatives

What Does it Take to Partner Successfully?

Learn from the Most Valuable Pharma Collaboration Award finalists at the eyeforpharma Philadelphia Awards.



Nominee profile: TransCelerate BioPharma, 19 pharma participants  

Why?
TransCelerate was launched in 2012 to accelerate industry progress through shared research and collaboration. It’s gained incredible traction since its inception, involving 19 of the biggest pharma companies worldwide while working tightly with FDA and EU regulators. 

What’s been achieved?

With so many parties (19) to key decision making, TransCelerate has achieved remarkable progress so far, particularly within clinical trials.

Standards have been set for data collection, risk-based monitoring and trial protocol, and the coalition has also prioritized support for clinical site investigators. Training procedures and data entry platforms have been standardized, giving considerable support to an overworked function.

How did they do it?

TransCelerate attribute their success to three principles:

- Leadership buy-in

- Unity around a single stakeholder

- Discipline in scoping realistic projects


Nominee profile: Fit2Me, AstraZeneca

Why?

AstraZeneca realized they were delivering cookie cutter patient education materials across their diabetes portfolio. The company needed a way to engage patients with personalized relevant advice, so developed a virtual coach service capable of creating custom lifestyle plans.

What’s been achieved?

Since launching in October, 2014, users are visiting their doctor 35% more frequently while refilling their medications 22% more often.

With many patient services vulnerable to ROI criticisms, a stand-out result for Fit2M is that new treatment revenue is covering the costs and delivering profit.

How did they do it?

Recognizing internal limitations and involving external experts was cited as a key driver of success. With digital capabilities in vogue across pharma, there is mounting competition for talent. If the industry wants to deliver on demand, they will have to compromise on going it alone, and seek new allies.  


Nominee profile: phactMI, 19 pharma participants  

Why?

phactMI set out with two objectives, to improve awareness of the value that pharma can deliver with Medical Information (MI), and secondly, to start cross-industry collaborations that improve how MI is made available to HCPs. It is taken seriously across the industry, with 19 leading companies participating.

What’s been achieved?

The team managed to deliver on the biggest MI cross-industry collaboration that has ever been attempted. HCPs can now access MI resources from all 19 companies and their brands in one location.

The website allows users to search by manufacturer or product name and be directed to the appropriate MI resources. Instead of having to search and remember product details across indications, HCPs can get it one place. It’s a huge timesaver.

How did they do it?

The team also cited the importance of leadership buy-in as critical.  Having all the decision makers in the room saved huge delays on activities needing to be approved.


Feeling inspired? Check out the other industry innovators battling it out for recognition at this year’s eyeforpharma Philadelphia Awards.


Since you're here...
... and value our content, you should sign-up to our newsletter. Sign up here

eyeforpharma Philadelphia Awards

May 2, 2016 - May 2, 2016, Philadelphia

The search for the most valuable and innovative patient-centric initiatives